Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding

NCT00389935 is registered in ClinicalTrials.gov with Northport Veterans Affairs Medical Center as lead sponsor.

NCT NCT00389935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00389935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Lead sponsor
Northport Veterans Affairs Medical Center
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2006
Completion date
July 31, 2011
Enrollment
14 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

arteriovenous malformation, hematochezia, hereditary hemorrhagic telangiectasia, melena